# Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day

> **NCT04585321** · PHASE1 · COMPLETED · sponsor: **Fidia Farmaceutici s.p.a.** · enrollment: 52 (actual)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** Diclofenac Sodium 140mg Medicated Plaster
- **DRUG:** Flector® topical plaster containing 180 mg of diclofenac hydroxyethylpyrrolidine equivalent to 140 mg of sodium diclofenac

## Key facts

- **NCT ID:** NCT04585321
- **Lead sponsor:** Fidia Farmaceutici s.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-28
- **Primary completion:** 2018-05-17
- **Final completion:** 2018-05-17
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585321, "Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04585321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*